Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
1d
Is high blood sugar tipping you closer to dementia? Why a new multi-national study may have answers
A collaboration of the Madras Diabetes Research Foundation, Chennai, Centre for Brain Research (CBR), Bengaluru and UK ...
Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
1. About lecanemab (generic name, brand name: LEQEMBI®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...
Khabargaon on MSN
Poor sleep leads to waste build-up; may cause dementia: Study
Poor sleep is increasingly figuring as one of the major culprits in causing neurodegenerative disorders, such as dementia and one of its forms, Alzheimer’s disease. Researchers led by scientists at ...
Alzheimer’s disease not only damages memory but also distorts the brain’s internal clock, disrupting the daily rhythms of hundreds of genes tied to brain health.
Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...
A new scientific report reveals that the protein aggregates associated with Parkinson’s disease are not inert clumps of ...
Researchers at the University of California, Irvine, have uncovered an unexpected molecular partnership that reshapes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback